Navigation Links
Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLC's Regulatory Announcement
Date:6/19/2008

ROSEAU, Commonwealth of Dominica, June 19 /PRNewswire/ -- Neuftec Limited, the proprietor of the original nano-particulate cerium oxide fuel catalyst technology, which recently issued a claim against Oxonica Energy Limited, a wholly owned subsidiary of Oxonica PLC, for infringement of its European Patent in the High Court of Justice, has commented on a fundamental inaccuracy in Oxonica's AGM Statement issued by Dr Matthews (CEO) on 19 June 2008.

Dr Kevin Matthews stated in the recent Regulatory Announcement that:

"In 2007 Neuftec acknowledged that Envirox as supplied by Nyacol, Oxonica's strategic partner, does not fall within the claims of their granted patent, EP(UK) 1299 508."

In May 2007, Oxonica provided Neuftec with a confidential statement containing what it claimed to be the chemical composition of Envirox sold to Petrol Ofisi. Based on that information alone, Neuftec confirmed in June 2007 that the second source product supplied to Petrol Ofisi did not come within the scope of claims of Neuftec's patent. Neuftec has never acknowledged that Envirox products sold to customers other than Petrol Ofisi did not infringe Neuftec's European patent.

Neuftec has obtained samples of Oxonica's Envirox formulation produced by Nyacol and conducted a preliminary analysis of the formulation. The results of this analysis confirm that the Nyacol Envirox formulation does not match the compostion statement issued to Neuftec by Oxonica. Neuftec Limited thus reserves its position regarding its rights to claim infringement in respect of all other formulations of Envirox supplied to other parties.

As reported earlier this month, the latest alleged infringement occurred when Oxonica shipped Envirox formulations to Italy for use in Italian Government laboratory emission testing. Neuftec is continuing it's investigations with customers, distributors & agents of Oxonica to determine the extent of the alleged infringement. Neuftec issued proceedings to seek an injunction against Oxonica as well as damages in relation to product already sold and delivery up or destruction of all articles that would infringe Neuftec's European patent.

About Neuftec

Neuftec is a research & development company that owns patents in the fuel catalyst technology sector used in the production of the first version of EnviroxTM (2001-2007) that was manufactured by Advanced Nanotechnology ("ANO") of Australia under a manufacturing licence granted by Oxonica with authorization from Neuftec.

On 29 February 2008, IP Australia issued a re-examination report in respect of Neuftec's Australian patent. The patent had been issued in 2006 with 10 claims. In the re-examination report, IP Australia confirmed the patentability of the 10 claims as originally granted in 2006 in re-examination proceedings initiated by Oxonica.


'/>"/>
SOURCE Neuftec Limited
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica
2. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
3. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
4. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
5. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
6. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
7. Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News
8. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
9. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
10. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
11. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
Breaking Biology Technology:
(Date:6/9/2016)... Finland , June 9, 2016 ... National Police deploy Teleste,s video security solution to ensure the ... France during the major tournament ... data communications systems and services, announced today that its video ... Prefecture to back up public safety across the ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):